Myotonometer Analyses of Muscles in Multiple Sclerosis Patients With Dysphagia
Primary Purpose
Multiple Sclerosis, Dysphagia, Swallowing Disorder
Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
DYMUS
Sponsored by
About this trial
This is an interventional other trial for Multiple Sclerosis
Eligibility Criteria
Inclusion Criteria:
- being diagnosed with Mc Donald's Multiple sclerosis (MS) in accordance with 2010 criteria,
- being between the ages of 18-45.
Exclusion Criteria:
- having psychological, orthopedic and other neurological disorders,
- pregnancy,
- having had an attack in the last 3 months,
- application of botulinum toxin in the last 6 months.
Sites / Locations
- Hasan Kalyoncu University
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Other
Other
Other
Arm Label
without swallowing problem
mild swallowing problem
severe swallowing problem
Arm Description
patients without swallowing problem
patients with mild swallowing problem
patients with severe swallowing problem
Outcomes
Primary Outcome Measures
Myotonometric Measurement
MyotonPro® device was used to measure muscles' viscoelastic parameters. The device is valid and reliable for measuring viscoelastic parameters (5, 6). Tonus, stiffness, elasticity of the muscles were recorded. Three measurements were bilaterally taken for each muscle. For each muscle, the average values of stiffness, tone and elasticity were retained as the main MyotonPRO outcomes. Myotonometric measurements were carried out for Masseter, Orbicularis Oris and Sternocleidomastoid (SKM) in supine position.
Secondary Outcome Measures
Eating Assessment Tool
Eating Assessment Tool was used to assess symptom of dysphagia. EAT-10 consisted of ten items, each of items was scored from 0 to 4. As the score increases, the patient's symptoms become deterioration.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04369092
Brief Title
Myotonometer Analyses of Muscles in Multiple Sclerosis Patients With Dysphagia
Official Title
Myotonometric Assessment of Muscles in Multiple Sclerosis Patients With Dysphagia
Study Type
Interventional
2. Study Status
Record Verification Date
April 2020
Overall Recruitment Status
Completed
Study Start Date
October 2, 2019 (Actual)
Primary Completion Date
December 28, 2019 (Actual)
Study Completion Date
January 30, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Tuba Maden
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Multiple Sclerosis is a chronic inflammatory autoimmune neurological disease characterized by the destruction of myelin in the central nervous system, grey matter and axonal loss. The prevalence of neurogenic dysphagia in this group of patients is estimated to be more than 30%. The aim of this study was investigating of Masseter, Orbicularis Oris, Sternocleidomastoid muscles' viscoelastic properties in MS patients with and without swallowing problems.
Detailed Description
The aim of this study was investigating of Masseter, Orbicularis Oris, Sternocleidomastoid muscles' viscoelastic properties in MS patients with and without swallowing problems. It carried out that myotonometric assessment of muscles in multiple sclerosis patients with dysphagia and comparison of these properties.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple Sclerosis, Dysphagia, Swallowing Disorder, Deglutition Disorders, Muscle Tonus
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
28 (Actual)
8. Arms, Groups, and Interventions
Arm Title
without swallowing problem
Arm Type
Other
Arm Description
patients without swallowing problem
Arm Title
mild swallowing problem
Arm Type
Other
Arm Description
patients with mild swallowing problem
Arm Title
severe swallowing problem
Arm Type
Other
Arm Description
patients with severe swallowing problem
Intervention Type
Other
Intervention Name(s)
DYMUS
Other Intervention Name(s)
evaluating oropharyngeal dysphagia
Intervention Description
DYsphagia in MUltiple Sclerosis (DYMUS) that was questionnare and Eating Assessment Tool (EAT-10) were used for assess swallowing problem. All individuals were classified according to DYMUS. The DYMUS Score was 1 or 2 was taken as mild swallowing problems, 3 or more was taken as severe swallowing problems. Patients were divided into three groups; first group that include patients without swallowing problems, second group that include patients with mild swallowing problems, third group that include severe swallowing problems.
Primary Outcome Measure Information:
Title
Myotonometric Measurement
Description
MyotonPro® device was used to measure muscles' viscoelastic parameters. The device is valid and reliable for measuring viscoelastic parameters (5, 6). Tonus, stiffness, elasticity of the muscles were recorded. Three measurements were bilaterally taken for each muscle. For each muscle, the average values of stiffness, tone and elasticity were retained as the main MyotonPRO outcomes. Myotonometric measurements were carried out for Masseter, Orbicularis Oris and Sternocleidomastoid (SKM) in supine position.
Time Frame
through study completion, average one hour
Secondary Outcome Measure Information:
Title
Eating Assessment Tool
Description
Eating Assessment Tool was used to assess symptom of dysphagia. EAT-10 consisted of ten items, each of items was scored from 0 to 4. As the score increases, the patient's symptoms become deterioration.
Time Frame
through study completion, average one hour
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
being diagnosed with Mc Donald's Multiple sclerosis (MS) in accordance with 2010 criteria,
being between the ages of 18-45.
Exclusion Criteria:
having psychological, orthopedic and other neurological disorders,
pregnancy,
having had an attack in the last 3 months,
application of botulinum toxin in the last 6 months.
Facility Information:
Facility Name
Hasan Kalyoncu University
City
Gaziantep
Country
Turkey
12. IPD Sharing Statement
Learn more about this trial
Myotonometer Analyses of Muscles in Multiple Sclerosis Patients With Dysphagia
We'll reach out to this number within 24 hrs